Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Lilly reports cannabinoid receptor antagonists

April 19, 1996

Dolasetron submitted for approval in U.S.

April 19, 1996

Cerebyx approvable in USA

April 19, 1996

Myotrophin NDA submission on track

April 19, 1996

GP-3269, new AK inhibitor from Gensia

April 19, 1996

New dopamine D3 ligand from Warner-Lambert

April 19, 1996

P&U's U-99363E shows high affinity for D4 receptors

April 19, 1996

BASF reports dopamine D3 ligands

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...